Skip to main content
. Author manuscript; available in PMC: 2014 Jul 8.
Published in final edited form as: Cancer Res. 2012 Nov 7;73(1):30–40. doi: 10.1158/0008-5472.CAN-11-3017

Fig. 5.

Fig. 5

Copy number analysis of CTCs and matched primary tumor. (A) Profiles from 250 CTCs and the primary tumor of patient #4009. (B) Profiles from 20 CTCs isolated from two independent blood draws (days 1 and 42) and the primary tumor of patient #4013. (C) Genomic profiles from sorting replicates of 20 CTCs at day 1 isolated from the same blood sample, then amplified and arrayed independently as well as 20 CTCs at day 87 and the primary tumor of patient #462. The primary tumor showed a low level gain in HER2 (arrow).